Alexandria Venture Investments was among the participants in a series A round for the cellular cancer therapeutics developer.

France-based cellular therapeutics developer Mnemo Therapeutics closed a €75m ($91m) series A round on Wednesday featuring Alexandria Venture Investments, a vehicle for life sciences real estate investment trust Alexandria Real Estate Equities.

Investment firm Casdin Capital led the round, which included Redmile, Emerson Collective and Sofinnova Partners, the last of which had taken part in a seed round of undisclosed size for the company in 2019.

Mnemo is developing CAR T cell therapies to treat cancer, based on research at…

Robert Lavine

Robert Lavine is special features editor for Global Venturing.